Clinico-hematological profile and morphological features on bone marrow aspirate in visceral leishmaniasis from non-endemic region

  • Dr. Arvind Kumar Gupta All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India.
  • Dr. Harish Chandra All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India.
  • Dr. Vandana Bharati All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India.
  • Dr. Neha Singh All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India.
  • Dr. Sanjeev Kishore All India Institute of Medical Sciences, Rishikesh, Uttarakhand, India.
Keywords: Leishmaniasis, Bone marrow aspirate, Pancytopenia, Plasmacytosis

Abstract

Introduction- Leishmaniasis which is caused by Leishmania donovani is considered to be a disease of lowland as climate and geographical factors play an important role in its distribution. However, recently few studies have reported leishmaniasis at higher altitude of Himalayan and sub Himalayan region of India. The present study was therefore conducted to study the clinico- hematological profile and the various morphological features on bone marrow examination associated with leishmaniasis in the non-endemic sub Himalayan region of India.

Material and Methods- The study included all the cases of leishmaniasis which were diagnosed on bone marrow examination over a period of one and half year in a medical institute situated in Uttarakhand state of India.

Results- The study included total 10 cases of visceral leishmaniasis diagnosed on bone marrow aspirate with fever (10 cases) and hepato-splenomegaly (7 cases) being most common clinical presentation and pancytopenia (9 cases) being the most common haematological finding. Bone marrow aspirate cytology showed that plasmacytosis (9 cases) and hemophagocytosis (8 cases) were the most common features. One case was clinically suspected as acute leukemia which turned out to be a case of leishmaniasis on bone marrow examination.

Conclusion- Leishmaniasis is emerging as an important major parasitic infection in the non-endemic Himalayan and sub Himalayan region of India. Fever, splenomegaly and pancytopenia are important clinical and peripheral blood examination features associated with this disease. Hemophagocytosis and plasmacytosis on bone marrow examination should prompt for vigilant search for LD bodies in bone marrow to avoid missing of diagnosis even in unsuspected cases.

Downloads

Download data is not yet available.

References

1.Herwaldt BL.“Leishmaniasis in Harrision’s Principles of Internal Medicine. FauciAS,Braunwald E, Kasper DL, et al.Eds,pp1296-1300 McGraw Hill, New York, NY,USA,17thed 2008.

2. Ponirovsky E N. Bi-regional meeting on leishmanias is to strengthen cross border collaboration for the control of leishmaniasis in Central Asian Countries (WHO regional office for Europe) and Middle East countries (WHO regional office for the Eastern Mediterranean) WHO and Turkmenistan. Med Parazitol 2015, 3 (3):62-63.

3. Bhunia GS, Kesari S, Jeyaram A, et al. Influence of topography on the endemicity of Kala-azar: a study based on remote sensing and geographical information system. Geospat Health. 2010;4(2):155-65. DOI:10. 4081 /gh.2010.197

4. Elnaiem DE, Schorscher J, Bendall A, Obsomer V, Osman ME, Mekkawi AM, et al. Risk mapping of visceral leishmaniasis: the role of local variation in rainfall and altitude on the presence and incidence of kala-azar in eastern Sudan. Am J Trop Med Hyg. 2003;68(1):10-7.

5. Chandra H, Chandra S, Kaushik RM. Visceral leishmaniasis with associated common, uncommon, and atypical morphological features on bone marrow aspirate cytology in nonendemic region. J Trop Med. 2013;2013. DOI:https://doi.org/10.1155/2013/861032

6. Mahajan SK, Machhan P, Kanga A, Thakur S, Sharma A, Prasher BS, et al. Kala-Azar at high altitude. J Commun Dis. 2004 Jun;36(2):117-20.

7. Kumar A, Vinita R, Thapliyal N, Saxena SR. Kala-azar--a case series from non endemic area, Uttarakhand. J Commun Dis. 2012;44(3):145-9.

8. Bhatia P, Haldar D, Varma N, Marwaha RK, Varma S. A case series highlighting the relative frequencies of the common, uncommon and atypical/unusual hematological findings on bone marrow examination in cases of visceral leishmaniasis. Mediter J Hematol Infect Dis. 2011;3(1):e2011035. DOI: 10.4084/ MJHID. 2011.035

9. Daneshbod Y, Dehghani SJ, Daneshbod K. Bone marrow aspiration findings in kala-azar. Acta Cytol. 2010;54(1):12-24. DOI:10.1159/000324961

10. Alvar J, Vélez ID, Bern C, Herrero M, Desjeux P, Cano J. Leishmaniasis worldwide and global estimates of its incidence. PLoS One. 2012;7(5):e35671. DOI: 10.1371/journal.pone.0035671. Epub 2012 May 31.

11. Ahmad S, Chandra H, Bhat NK, Dhar M, Shirazi N, Verma SK. North Indian state of Uttarakhand: a new hothouse of visceral leishmaniasis. Trop Doct. 2016;46 (2): 111-3. DOI: 10.1177/0049475515609245. Epub 2015 Oct 14.

12. Joshi A, Gulati A, Pathak VP, Bansal R. Post-Kala-Azar-dermal-leishmaniasis: an unusual presentation from Uttarachal (a non-endemic hilly region of India). Indian J Dermatol Venereol Leprol. 2002;68(3):171-3.

13. Prieto Tato LM, La Ordem Izquierdo E, Guillen Martin S, Salcedo Lobato E, Garcia Esteban C, Garcia Bermejo I, et al. Visceral childhood leishmaniasis: diagnosis and treatment. An Pediatr (Barc) 2010;72 (5):347-351. DOI:10.1016/j.anpedi.2009.12.020

14. Varma N, Naseem S. Hematologic Changes in Visceral Leishmaniasis/Kala Azar. Indian J Hematol Blood Transfus. 2010; 26(3):78–82. DOI: 10.1007/s 12288-010-0027-1.

15. Singh OP, Sundar S. Developments in diagnosis of visceral leishmaniasis in the elimination era. Journal of parsasitology research. 2015;2015. DOI: https://doi. org / 10. 1155/2015/239469.
CITATION
DOI: 10.17511/jopm.2019.i06.12
Published: 2019-06-30
How to Cite
Dr. Arvind Kumar Gupta, Dr. Harish Chandra, Dr. Vandana Bharati, Dr. Neha Singh, & Dr. Sanjeev Kishore. (2019). Clinico-hematological profile and morphological features on bone marrow aspirate in visceral leishmaniasis from non-endemic region. Tropical Journal of Pathology and Microbiology, 5(6), 408-412. https://doi.org/10.17511/jopm.2019.i06.12
Section
Original Article